Comment on "the matrix metalloproteinases as pharmacological target in osteoarthritis: statins may be of therapeutic benefit".
Liu
Yu-Ping
YP
Yu
Guang-Rong
GR
D050197:Atherosclerosis / Q000473:pathology; D002356:Cartilage / Q000378:metabolism / Q000473:pathology; D018450:Disease Progression; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007249:Inflammation; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D008954:Models, Biological; D010003:Osteoarthritis / Q000201:enzymology* / Q000378:metabolism / Q000628:therapy*
D004791:Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D020782:Matrix Metalloproteinases